Sanz, Juan CarlosDe Ory, Fernando deGuisasola, Maria EulaliaBalfagon, Pilar2020-06-162020-06-162018-01J Clin Lab Anal . 2018 Jan;32(1):e22203.0887-8013http://hdl.handle.net/20.500.12105/10445Serology for type-specific herpes simplex virus (HSV) is based on the use of the respective glycoprotein G (gG). Chemiluminescent immunoassay (CLIA; BIO-FLASH® , Biokit, Spain), ELISA (HerpeSelect® , Focus, USA), and immunoblot (IB; Virotech, Germany) for detecting HSV-1- and HSV-2-specific IgG were compared using 384 serum samples received for HSV serology. The samples were classified as positive or negative according to a consensus criterion. For HSV-1, 262 samples were positive and 118 were negative (four samples were unclassifiable). IB showed agreement, sensitivity, and specificity values of 98.68%, 98.47% and 99.15%, respectively. The corresponding figures for CLIA and ELISA were 98.95%, 99.24% and 98.31%, and 98.16%, 99.62% and 94.92%, respectively. For HSV-2, 106 samples were positive and 278 were negative. Agreement, sensitivity, and specificity of IB were 99.48%, 98.11%, and 100%, respectively. The corresponding figures for CLIA and ELISA were 99.48%, 99.06% and 99.64%, and 98.18%, 99.06% and 97.84%, respectively. The three methods showed excellent and equivalent performance characteristics for the detection of type-specific IgG to HSV-1 and HSV-2.engAMhttp://creativecommons.org/licenses/by-nc-sa/4.0/SimplexvirusAntibodies, ViralEnzyme-Linked Immunosorbent AssayHerpes SimplexHumansImmunoblottingImmunoglobulin GLuminescent MeasurementsAtribución-NoComercial-CompartirIgual 4.0 Internacional28332725321e2220310.1002/jcla.222031098-2825Journal of clinical laboratory analysisopen access